Answers are grounded in this paper and cite their sources.
Portal hypertension (PH) is a clinical syndrome, characterized by elevated pressure gradient between portal vein and inferior vena cava. These elevated pressures gradient due to increased vascular resistance and/or increased volume of blood flowing through the portal vein circulation, results in blood outflow difficulty from portal vein to hepatic veins and inferior vena cava, and eventually cause life-threatening complications including ascites, gastroesophageal varices, and hepatic encephalopathy. In spite of the severity of PH, it is hard to early diagnosis, as no liver-related symptom appears during the early stage. It is important to dynamically monitor the portal vein pressure gradient in high-risk patients with cirrhosis during disease progression. Current practical guidelines recommend hepatic venous pressure gradient (HVPG) measurement as the gold-standard tool to diagnose PH. Although the HVPG measurement is safe and feasible, it is an invasive procedure guided by X-ray fluoroscopy and requires sedation, which is not suitable to repeatedly perform as a monitoring tool. Moreover, HVPG measurement is relatively expensive and may be accommpanied by a series of complications (leakage, hematoma, arteriovenous fistulae, or Horner syndrome). There has been growing interest in research to develop an accurate, noninvasive alternative to HVPG. In the past decades, several studies have found an inverse relationship between ambient pressure and the subharmonic amplitude derived from ultrasound contrast agents (UCAs), revealing the possibility of subharmonic aided pressure estimation (SHAPE) measurement for determining portal venous pressure based on ultrasound, characterized by noninvasive, real-time, and radiation-free. SHAPE has been studied in several fields, such as interstitial fluid pressures in breast cancers, left ventricular pressures, and fluctuation in portal pressures. However, the majority of them are limited to experimental or animal studies, and few clinical trials on PH have been published until now. Considering the large amounts of patients with liver cirrhosis in China, which is the leading cause of PH, it is urgently needed to promote SHAPE to diagnose PH as soon as possible. The SHAPE is based on the inverse relationship between the subharmonic amplitude of UCAs and the ambient pressure. Both the simulation and the experiment show that the radiated pressure from microbubbles, gas-filled, encapsulated microbubbles (diameter <10 μm), will produce nonlinear oscillations at various frequencies, ranging from the subharmonic (f0/2, i.e., half of the fundamental transmission frequency), the second harmonic (2f0) to ultra-harmonics (2/3f0), under acoustic pressure above 200 kPa. Although fundamental and second harmonic signal, as well as subharmonic signal, show decreases with an increase in ambient pressure over a range of 0–186 mmHg, subharmonic signal changes most, four to five times than fundamental and second harmonic signal, the explanation why to choose subharmonic pressure estimation. The other advantages of subharmonic estimating pressure change include generation only by UCA, and excellent signal-to-noise ratio and contrast resolution. However, subharmonic change shows different generation thresholds and nonlinear change, which resembles an S-curve with occurrence (roughly 100–200 kPa), growth (roughly 300–600 kPa), and saturation stages (roughly 600 kPa to contrast agent destruction), during the increased acoustic pressure. The optimal acoustic pressure or medical index needs to be chosen on the inflection plot of the growth stage, corresponding to the highest subharmonic sensitivity (Figure 1A,B). To explore an optimization UCA for investigating the ambient pressure sensitivity in diagnostic ultrasound, two UCAs (Levovist [Schering AG, Berlin, Germany] and Sonazoid [GE Healthcare, Oslo, Norway]) were used. The results showed that simulations of Levovist using a rectangular driving pulse showed an almost linear reduction in the subharmonic component as overpressure is increased, and the pressure sensitivity of Levovist was found to be 0.88 dB/kPa; while for Sonazoid, a sensitivity of 1.14 dB/kPa had been found, although the reduction is not completely linear as a function of the ambient pressure. A similar finding was found in another trial in vitro, which revealed that the Sonazoid yielded the highest gradient in subharmonic amplitude than the other four UCAs (Levovist [Schering AG, Berlin, Germany], Definity [Lantheus Medical Imaging, N.Billerica, MA], Optison [GE Healthcare, Princeton, NJ, USA] and ZFX [Zhifuxian, Xinqiao Hospital, China]), as the pressure was changed from 0 to 186 mmHg and an r value of 0.99. Additionally, they conducted an experimental system for in vitro SHAPE using a modified Logiq 9 scanner on a convex probe with a frequency range from 1.5 to 4.5 MHz and acoustic pressures from 0 to 3.34 MPa. The results obtained optimum sensitivity at a transmit frequency of 2.5 MHz and acoustic pressure of 0.35 MPa using Sonazoid and proved that Sonazoid was the most sensitive for subharmonic pressure estimation. Moreover, despite that concentration has little effect on subharmonic change, subharmonic change is affected by many other factors, such as depth, pulse shape, cycle, bubble size, size distribution, initial surface tension, and so forth. Subharmonic is dependent on incident acoustic outputs and ambient pressure. A significantly higher correlation of the SHAPE gradient with changing pressures for the broadband pulses as compared to the narrowband pulses in both in vitro and in vivo results. Previous studies have also shown the ability to conduct subharmonic imaging in the hepatic vascular system of both canines using this curvilinear probe with Sonazoid. Despite the efficacy of in vitro and animal studies, portal pressure change was almost artificially set, which is impossible in clinical research. Moreover, conversion factor value varies among studies, which increases the difficulty to use absolute subharmonic value for pressure estimation. The SHAPE method proposed by Thomas Jefferson University shed light on clinical application,1 measuring relative change between portal vein and hepatic vein subharmonic signal on the same depth, which is similar to HVPG, subtracting the free hepatic venous pressure from the wedged hepatic venous pressure. Their result was also encouraging, showing a good agreement with HVPG (r = 0.68–0.82), indicating that SHAPE could potentially be a cost and time-effective technique for monitoring portal pressures, with a sensitivity of 90%–91% and specificity of 80%–82% for diagnosing clinically significant PH (Figure 1C,D).2, 3 Then, they further explored the effects of SHAPE in differentiating treatment prognosis using the clinical HVPG measurements as the reference standard and the liver function tests and clinical indicators as the efficacy criteria. There was a significantly larger SHAPE signal reduction in the group who were classified as treatment responders compared to the nonresponders. The SHAPE measurement of patients matched the corresponding clinical outcomes. In addition, as SHAPE is a quantitative technique based on RF data, the measurements have good reproducibility and reported standard deviations <1 dB. Machado et al.4 conducted a trial with 131 patients (31 subclinical PH and 33 clinical PH), revealing two readers achieved for PH sensitivity of 77%–100%, specificity of 61%–88%, and receiver operating characteristic curve area of 0.70–0.93. The intraobserver reproducibility, assessed by κ value of 0.66. This cohort indicated that the presence of optimized subharmonic imaging signals inside the hepatic vein can be a qualitative screening test for PH, which could reduce the necessity for invasive diagnostic procedures. Although the practical application of SHAPE is promising, there have some challenges. First, optimization of parameters to improve the correlation coefficient. A trial5 in 20 patients undergoing dialysis for chronic kidney disease showed a moderate correlation between SHAPE and HVPG (r = 0.45), which is lower than the previous one. The cause of the variable and unsatisfied correlation coefficient needed to be solved. The fact is that the majority of commercially available ultrasound systems do not have an subharmonic imaging mode and the required optimization algorithm implemented on their systems. Moreover, a specific UCA is needed. Monodisperse microbubbles specifically designed for SHAPE using a commercially available microfluidics device (Solstice Pharmaceuticals) have the potential to greatly increase sensitivity to hydrostatic pressure compared to relying on polydisperse agents designed for diagnostic imaging. In addition, the variable correlation coefficient between SHAPE and liver fibrosis is presented in PH patients with other comorbidity (e.g., chronic kidney disease).5 Further large-scale prospective studies are needed to perform to evaluate the clinical application of SHAPE. In conclusion, the subharmonic amplitude decreases linearly with increases in ambient fluid pressure. This response forms the basis of a technique referred to as SHAPE measurement. The SHAPE shows concordance with HVPG values, and can be used as a clinical tool to estimate PH noninvasively in the future. Yi Dong and Yun-Lin Huang conceived and carried out the manuscript. Yun-Lin Huang, Juan Cheng, Xin-Liang Xu, and Sheng Chen cowrote the manuscript. Yi Dong and Wen-Ping Wang made a critical revision of the manuscript for important intellectual content. All authors were involved in writing the paper and had final approval of the submitted and published versions. This study was supported by Sino-German Mobility Programme of NSFC and DFG, Grant Number: M-0504; National Natural Science Foundation of China, Grant Number: 82071942, 82272013; Shanghai Pujiang Program, Grant Number: 2020PJD008; and Clinical Research Plan of SHDC, Grant Number: SHDC2020CR1031B, SHDC2020CR4060. The authors declare no conflict of interest. The authors have nothing to report. The authors have nothing to report.
No takes yet. Share an insight, caveat, or question.
Huang et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: